Clinical Trials Logo

Clinical Trial Summary

The aim of this study is to evaluate the possible immunologic effects of spirulina in children with beta thalassemia.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT02674607
Study type Interventional
Source Tanta University
Contact
Status Completed
Phase N/A
Start date October 2015
Completion date October 2017

See also
  Status Clinical Trial Phase
Not yet recruiting NCT03276455 - Gene Therapy for Beta-Thalassemia Major Using Autologous Hematopoietic Stem Cell Genetically Modified Phase 1/Phase 2
Terminated NCT01571635 - Study to Determine the Safety and Tolerability of Sotatercept (ACE-011) in Adults With Beta( β)- Thalassemia. Phase 2
Completed NCT04092205 - Phase 2a Pilot Study of NBMI Treatment in Patients With Beta Thalassemia Major, Requiring Iron Chelation Phase 2
Completed NCT02744560 - Effect of Spirulina on Liver Iron Concentration in Beta Thalassemic Children With Hepatitis C N/A
Recruiting NCT04353986 - PK of SOF/LED in HCV - Infected Adolescents With Haematological Disorders Phase 3
Not yet recruiting NCT02173951 - An Algorithm to Start Iron Chelation in Minimally Transfused Young Beta-thalassemia Major Patients Phase 2/Phase 3
Completed NCT03947632 - Anthropometric Measurements in Children Having Transfusion-dependent Beta Thalassemia
Withdrawn NCT04776850 - Pre-transplant Immunosuppression and Donor Stem Cell Transplant for the Treatment of Severe Hemoglobinopathies Early Phase 1
Completed NCT02744105 - Effect of Spirulina on Liver Fibrosis by Transient Elastography in Beta Thalassemic Children With Hepatitis C N/A
Completed NCT02744547 - Effect of Spirulina on Serum Hyaluronic Acid in Beta Thalassemic Children With Hepatitis C N/A
Active, not recruiting NCT03101423 - Monitoring of Chimerism After Transplantation in Patients With β Thalassemia Major and the Treatment Strategies for the Reduction of Chimerism N/A
Completed NCT02671695 - Effect of Spirulina Compared to Amlodipine on Cardiac Iron Overload in Children With Beta Thalassemia N/A
Completed NCT00658385 - Assess the Feasibility and Safety of Granulocyte Colony Stimulating Factor (GCSF) Mobilization of CD34+ Hematopoietic Progenitor Cells in Patients With Betathalassemia Major N/A